NCT01715012View on ClinicalTrials.gov

Study of ST266 in Diabetic Subjects With Deep Burns Managed With Skin Grafts

PHASE2TerminatedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

January 31, 2015

Study Completion Date

March 31, 2015

Conditions
Third Degree BurnsDiabetes
Interventions
BIOLOGICAL

ST266

ST266 is applied daily by spray to burn wound and skin graft donor site

DRUG

Saline

Saline is applied daily by spray to burn wound and skin graft donor site

Trial Locations (1)

43210

The Burn Unit of the Wexner Medical Center at The Ohio State University., Columbus

Sponsors
All Listed Sponsors
lead

Noveome Biotherapeutics, formerly Stemnion

INDUSTRY

NCT01715012 - Study of ST266 in Diabetic Subjects With Deep Burns Managed With Skin Grafts | Biotech Hunter | Biotech Hunter